(M4) Insights into Retinal Health: Bridging Payer Gaps for Timely and Equitable Care

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

A growing number of therapeutic options for retinal diseases are on the market which reflect disease-targeted therapeutic advances for age-related wet macular degeneration, diabetic macular edema, and diabetic retinopathy. In navigating the complexities of managing patients with retinal disease, it is imperative to recognize the multifaceted barriers that hinder optimal care delivery. Key challenges encompass understanding its substantial burden on individuals and society and addressing the prevailing health disparities that impede equitable access to treatment. Faculty for this session will provide an overview of the latest drug advancements in age-related macular degeneration, diabetic macular edema, and diabetic retinopathy to align managed care strategies that support appropriate and timely treatment and bridge access and utilization of care for marginalized groups.